DRD1 and Huntington disease: As a proof-of-concept study, we showed the MORF method allows a Drd1 BAC transgene to express a membrane-bound fluorescent maker protein in about 1% of D1-MSNs, which allows visualization of their dendritic architecture, development, degenerative pathology in an HD mouse model.